Research Overview
KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH, positions 11-13) that has been studied in laboratory settings. Research demonstrates KPV operates through melanocortin receptor-independent pathways, making it distinct from its parent molecule.
Molecular Mechanisms
KPV enters cells via the PepT1 oligopeptide transporter with high affinity (Km ~160 μM in Caco2 cells). Studies show the peptide accumulates in the nucleus within 5 hours, where it competitively disrupts the interaction between p65RelA and importin-α3, blocking NFκB nuclear translocation.[1]
At nanomolar concentrations (10 nM), KPV also suppresses all three major MAPK subfamilies (ERK1/2, JNK, p38) in intestinal epithelial cells. This mechanism occurs independently of melanocortin receptors and reduces inflammatory cytokine expression.[2]
Gastrointestinal Inflammation Models
Oral KPV administration in murine DSS and TNBS colitis models demonstrated significant reductions in:
- Colonic myeloperoxidase activity (~50% decrease, p<0.05)
- Pro-inflammatory cytokine mRNA (IL-6, IL-12, TNF-α, IFN-γ)
- Epithelial damage and cell infiltration
Research indicates KPV’s efficacy correlates with PepT1 expression, which becomes upregulated during IBD.[1]
Airway and Pulmonary Studies
In bronchial epithelial cells (16HBE14o-), KPV reduced TNFα-induced responses:
- NFκB reporter activity decreased at concentrations ≥1 μg/ml
- IL-8 mRNA reduced by ~35% (p<0.05)
- MMP-9 gelatinolytic activity returned to baseline levels
- Eotaxin secretion significantly attenuated
These findings suggest potential applications in research models.[2]
Immune Cell Modulation
Human Jurkat T cells and immune populations express functional PepT1, enabling KPV uptake. Studies demonstrate that 10 nM KPV stabilizes IκBα protein levels and reduces IL-8 transcription by ~40% following TNFα stimulation.
During certain conditions, PepT1 expression increases in lamina propria macrophages and peripheral T cells, providing delivery pathways for peptide-based research tools.[1]
Dermatological Research
KPV retains activity without activating MC1R, the melanogenesis receptor. This property makes it useful for research where pigmentation effects would confound results.[3]
Stereoisomers like KdPT (Lys-D-Pro-Thr) show enhanced proteolytic stability. Research on sebocytes demonstrated KdPT suppresses IL-1β-mediated cytokine signaling, relevant to acne pathogenesis studies.
Structure-Activity Relationships
The tripeptide KPV represents the minimal α-MSH sequence retaining activity. Deletion studies confirm truncation beyond KPV eliminates efficacy.[4]
D-amino acid substitutions (KdPV, KPdV, dKPV) preserve activity while enhancing proteolytic resistance. Glycoalkylation of the lysine residue increases stability but eliminates certain properties, demonstrating structure-dependent bioactivity profiles.[5]
Research Use Only: KPV is intended for in vitro laboratory research and experimental protocols. All findings referenced represent preclinical research models and are not validated for therapeutic applications.
References
- Dalmasso G, Charrier–Hisamuddin L, Thu Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Elsevier BV; 2008. https://doi.org/10.1053/j.gastro.2007.10.026
- Land S. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. International Journal of Physiology, Pathophysiology and Pharmacology. 2012;4(2):59–73.
- Böhm M, Luger T. Are melanocortin peptides future therapeutics for cutaneous wound healing? Wiley; 2019. https://doi.org/10.1111/exd.13887
- Luger TA, Brzoska T. α-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Elsevier BV; 2007. https://doi.org/10.1136/ard.2007.079780
- Songok AC, Panta P, Doerrler WT, Macnaughtan MA, Taylor CM. Structural modification of the tripeptide KPV by reductive “glycoalkylation” of the lysine residue. Public Library of Science (PLoS); 2018. https://doi.org/10.1371/journal.pone.0199686